Viruses associated with human cancer.

Novel polyomaviruses of nonhuman primates: genetic and serological predictors for the existence of multiple unknown polyomaviruses within the human population. PLoS Pathog (2013) 1.53

Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges. AIDS (2014) 1.41

Viral manipulation of DNA repair and cell cycle checkpoints. DNA Repair (Amst) (2009) 1.37

Human Papillomavirus (HPV)-associated Oral Cancers and Treatment Strategies. J Dent Res (2014) 1.15

The history of tumor virology. Cancer Res (2008) 1.14

Torque Teno Virus (TTV) distribution in healthy Russian population. Virol J (2009) 1.14

Cancer biomarkers: are we ready for the prime time? Cancers (Basel) (2010) 1.10

Single nanoparticle detectors for biological applications. Nanoscale (2012) 1.10

High-throughput RNA sequencing-based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project. J Virol (2014) 1.07

Hepatitis viruses and non-Hodgkin's lymphoma: A review. World J Virol (2012) 0.99

Expression of mitochondrial non-coding RNAs (ncRNAs) is modulated by high risk human papillomavirus (HPV) oncogenes. J Biol Chem (2012) 0.98

Dr.VIS: a database of human disease-related viral integration sites. Nucleic Acids Res (2011) 0.95

Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung. Br J Cancer (2016) 0.94

Expression of endogenous retroviruses is negatively regulated by the pluripotency marker Rex1/Zfp42. Nucleic Acids Res (2012) 0.93

Herpes and polyoma family viruses in thyroid cancer. Oncol Lett (2016) 0.92

Oncomodulation by human cytomegalovirus: novel clinical findings open new roads. Med Microbiol Immunol (2010) 0.91

Sensitive detection of viral transcripts in human tumor transcriptomes. PLoS Comput Biol (2013) 0.90

The E1B19K oncoprotein complexes with Beclin 1 to regulate autophagy in adenovirus-infected cells. PLoS One (2011) 0.90

Human papillomavirus-16 E7 interacts with glutathione S-transferase P1 and enhances its role in cell survival. PLoS One (2009) 0.89

The modulation of apoptosis by oncogenic viruses. Virol J (2013) 0.89

Epigenetic mechanisms in virus-induced tumorigenesis. Clin Epigenetics (2011) 0.88

Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection. Proc Natl Acad Sci U S A (2015) 0.86

Honey and cancer: sustainable inverse relationship particularly for developing nations-a review. Evid Based Complement Alternat Med (2012) 0.86

Modulation of autophagy-like processes by tumor viruses. Cells (2012) 0.85

H3K9me3-binding proteins are dispensable for SETDB1/H3K9me3-dependent retroviral silencing. Epigenetics Chromatin (2011) 0.85

Serodiagnosis for tumor viruses. Semin Oncol (2014) 0.85

How virus persistence can initiate the tumorigenesis process. World J Virol (2013) 0.84

The Role of Gammaherpesviruses in Cancer Pathogenesis. Pathogens (2016) 0.83

Virus-Clip: a fast and memory-efficient viral integration site detection tool at single-base resolution with annotation capability. Oncotarget (2015) 0.83

View and review on viral oncology research. Infect Agent Cancer (2010) 0.83

Cell Fusion in the War on Cancer: A Perspective on the Inception of Malignancy. Int J Mol Sci (2016) 0.81

The human papillomavirus type 16 E7 oncoprotein targets Myc-interacting zinc-finger protein-1. Virology (2011) 0.80

Evidences suggesting involvement of viruses in oral squamous cell carcinoma. Patholog Res Int (2013) 0.80

LANA-Mediated Recruitment of Host Polycomb Repressive Complexes onto the KSHV Genome during De Novo Infection. PLoS Pathog (2016) 0.78

Nuclear import of cutaneous beta genus HPV8 E7 oncoprotein is mediated by hydrophobic interactions between its zinc-binding domain and FG nucleoporins. Virology (2013) 0.78

Does honey have the characteristics of natural cancer vaccine? J Tradit Complement Med (2012) 0.77

Higher methylation intensity induced by EBV LMP1 via NF-κB/DNMT3b signaling contributes to silencing of PTEN gene. Oncotarget (2016) 0.77

Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer. Infect Agent Cancer (2014) 0.77

The Modulation of Apoptotic Pathways by Gammaherpesviruses. Front Microbiol (2016) 0.76

Epidemiological patterns of cervical human papillomavirus infection among women presenting for cervical cancer screening in North-Eastern Nigeria. Infect Agent Cancer (2015) 0.76

Initial amplification of the HPV18 genome proceeds via two distinct replication mechanisms. Sci Rep (2015) 0.76

Functional implications of mitochondrial reactive oxygen species generated by oncogenic viruses. Front Biol (Beijing) (2014) 0.75

Viruses in cancer cell plasticity: the role of hepatitis C virus in hepatocellular carcinoma. Contemp Oncol (Pozn) (2015) 0.75

Meeting report: Signal transduction meets systems biology. Cell Commun Signal (2012) 0.75

Immunotherapy against cancer-related viruses. Cell Res (2016) 0.75

The ovarian cancer oncobiome. Oncotarget (2017) 0.75

Virus proteins similar to human proteins as possible disturbance on human pathways. Syst Synth Biol (2014) 0.75

Major Histocompatibility Complex Class II HLA-DRα Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8. J Virol (2016) 0.75

Circulating interleukin-10 levels and human papilloma virus and Epstein-Barr virus-associated cancers: evidence from a Mendelian randomization meta-analysis based on 11,170 subjects. Onco Targets Ther (2016) 0.75

Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing. Int J Gynecol Cancer (2014) 0.75

Thrombocytopenia in Pregnancy. Maedica (Buchar) (2016) 0.75

Chest neoplasms with infectious etiologies. World J Radiol (2011) 0.75

Human Papilloma Virus' Life Cycle and Carcinogenesis. Maedica (Buchar) (2016) 0.75

The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers. Front Oncol (2017) 0.75

TRIM29 promotes DNA virus infections by inhibiting innate immune response. Nat Commun (2017) 0.75

Viral Causes of Lymphoma: The History of Epstein-Barr Virus and Human T-Lymphotropic Virus 1. Virology (Auckl) (2017) 0.75

Essential role of HCMV deubiquitinase in promoting oncogenesis by targeting anti-viral innate immune signaling pathways. Cell Death Dis (2017) 0.75

Epigenetic Alterations in Human Papillomavirus-Associated Cancers. Viruses (2017) 0.75

Initial sequencing and analysis of the human genome. Nature (2001) 212.86

Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22

THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION? Proc R Soc Med (1965) 40.52

Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet (1996) 39.80

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (1994) 39.60

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 37.89

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A (1980) 30.08

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell (1990) 20.60

Hepatitis C virus infection. N Engl J Med (2001) 18.67

T antigen is bound to a host protein in SV40-transformed cells. Nature (1979) 17.78

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54

Global epidemiology of hepatitis C virus infection. Lancet Infect Dis (2005) 16.44

Cancer. p53, guardian of the genome. Nature (1992) 16.36

Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46

A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A (1983) 14.73

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. Lancet (1964) 14.21

Classification of papillomaviruses. Virology (2004) 14.16

Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell (1979) 14.05

The global health burden of infection-associated cancers in the year 2002. Int J Cancer (2006) 13.57

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet (1981) 13.54

Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A (1996) 12.89

Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science (1990) 12.88

Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A (1982) 12.84

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell (1988) 12.69

Human papillomavirus and cervical cancer. Lancet (2007) 12.47

New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet (1971) 12.13

Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet (1971) 11.92

The p53 proto-oncogene can act as a suppressor of transformation. Cell (1989) 11.67

Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet (1970) 11.61

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (1989) 11.53

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (1988) 10.98

Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature (2007) 10.94

Hepatitis B virus infection--natural history and clinical consequences. N Engl J Med (2004) 10.91

E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science (1992) 10.28

A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J (1984) 10.28

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell (1985) 10.13

Retracted Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog (2006) 10.08

Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell (1982) 9.27

Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol (2005) 9.00

The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol (1989) 8.68

Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology (2004) 8.36

SOME POSSIBLE EFFECTS OF NURSING ON THE MAMMARY GLAND TUMOR INCIDENCE IN MICE. Science (1936) 8.23

Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog (2007) 8.01

Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta (1996) 7.79

Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J (1989) 7.69

Hepatitis B virus biology. Microbiol Mol Biol Rev (2000) 7.58

Cellular targets for transformation by the adenovirus E1A proteins. Cell (1989) 7.53

The vacuolating virus, S.V. 40. Proc Soc Exp Biol Med (1960) 7.32

Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell (1991) 7.16

Identification of a third human polyomavirus. J Virol (2007) 7.06

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 6.96

Oncogenic forms of p53 inhibit p53-regulated gene expression. Science (1992) 6.73

HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J (1989) 6.60

A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol (1992) 6.56

The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell (1988) 6.28

Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature (1982) 6.09

Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol Cell Biol (1981) 6.02

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell (1995) 5.97

Viral hepatitis C. Lancet (2003) 5.81

The molecular genetics of cellular oncogenes. Annu Rev Genet (1984) 5.72

Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell (1984) 5.56

Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature (1984) 5.53

Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature (2005) 5.50

Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med (2002) 5.34

The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci U S A (1991) 5.31

Unravelling hepatitis C virus replication from genome to function. Nature (2005) 5.25

A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun (1997) 5.25

Human T-lymphotropic retroviruses. Nature (1985) 5.04

Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol (1987) 5.00

Global epidemiology of HTLV-I infection and associated diseases. Oncogene (2005) 4.77

p53 inhibition by the LANA protein of KSHV protects against cell death. Nature (2000) 4.74

Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer (2007) 4.69

Evasion of intracellular host defence by hepatitis C virus. Nature (2005) 4.58

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med (1998) 4.48

Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature (1992) 4.36

Characteristics of an assay for Rous sarcoma virus and Rous sarcoma cells in tissue culture. Virology (1958) 4.36

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology (2001) 4.28

Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci U S A (1992) 4.27

Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell (1998) 4.21

E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res (1996) 4.14

Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol Cell Biol (1986) 4.14

Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell (1993) 4.10

Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene (1987) 4.02

The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science (1987) 4.01

Integrating genetic approaches into the discovery of anticancer drugs. Science (1997) 3.99

Mechanisms of human papillomavirus-induced oncogenesis. J Virol (2004) 3.95

SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell (1989) 3.88

The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc Natl Acad Sci U S A (1994) 3.88

Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J (1987) 3.81

Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci U S A (1988) 3.73

Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science (1997) 3.70

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet (2002) 3.67

The action of oncogenes in the cytoplasm and nucleus. Science (1985) 3.62

Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J (1988) 3.61

Human papillomavirus immortalization and transformation functions. Virus Res (2002) 3.58

Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol (1995) 3.57

Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci U S A (2004) 3.43

Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol Cell Biol (1983) 3.39

Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol (1994) 3.34

The pathogenic potential of endogenous retroviruses: facts and fantasies. Trends Microbiol (1999) 3.32

Kinase requirements in human cells: I. Comparing kinase requirements across various cell types. Proc Natl Acad Sci U S A (2008) 1.95

Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J Virol (2007) 1.73

The papillomavirus E7 proteins. Virology (2013) 1.28

Cancer associated human papillomaviruses. Curr Opin Virol (2012) 1.25

Spectroscopic diagnosis and imaging of invisible pre-cancer. Faraday Discuss (2004) 1.25

Prognostic implications of HPV in oropharyngeal cancer. N Engl J Med (2010) 1.11

Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines. Proc Natl Acad Sci U S A (2013) 1.04

Activation of cap-dependent translation by mucosal human papillomavirus E6 proteins is dependent on the integrity of the LXXLL binding motif. J Virol (2012) 0.95

The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species. PLoS Pathog (2013) 0.94

Kinase requirements in human cells: V. Synthetic lethal interactions between p53 and the protein kinases SGK2 and PAK3. Proc Natl Acad Sci U S A (2010) 0.93

Functional genetic screen for genes involved in senescence: role of Tid1, a homologue of the Drosophila tumor suppressor l(2)tid, in senescence and cell survival. Mol Cell Biol (2004) 0.92

The human papillomavirus type 8 E6 protein interferes with NOTCH activation during keratinocyte differentiation. J Virol (2013) 0.88

Biochemical and functional interactions of human papillomavirus proteins with polycomb group proteins. Viruses (2013) 0.81

Human papillomavirus type 16 E7 oncoprotein engages but does not abrogate the mitotic spindle assembly checkpoint. Virology (2012) 0.79

Human papillomavirus type 16 E7 oncoprotein inhibits the anaphase promoting complex/cyclosome activity by dysregulating EMI1 expression in mitosis. Virology (2013) 0.79

The LKB1 tumor suppressor differentially affects anchorage independent growth of HPV positive cervical cancer cell lines. Virology (2013) 0.77

p16 in HPV-associated cancers. Oncotarget (2013) 0.77

Noninvasive assessment of mitochondrial organization in three-dimensional tissues reveals changes associated with cancer development. Int J Cancer (2014) 0.76

American Idol and NIH grant review--redux. Cell (2006) 0.75